Xebra Brands Ltd (XBRA) | Finanzwire

Basculer en Français

8295	Companies
114863	Keywords
55304	Articles
62446	Press releases

Home
Companies
Xebra Brands Ltd

BRIEF

published on 04/04/2024 at 15:15, 7 months 16 days ago

Xebra Brands Submits Third Product Submission to COFEPRIS, Expanding Elements Brand CBD Lineup

CBD Products Xebra Brands Mexican Market COFEPRIS Elements Topical Lotion
PRESS RELEASE

published on 04/04/2024 at 15:10, 7 months 16 days ago

Xebra Brands Submits Third Product Submission to COFEPRIS, Expanding Elements Brand CBD Lineup
Xebra Brands Ltd. submits its third product application for approval to COFEPRIS in Mexico for domestic production, expanding its Elements brand lineup with a topical lotion infused with premium CBD extract

CBD Products Xebra Brands Ltd. Mexico Market COFEPRIS Approval Topical Lotion
BRIEF

published on 03/26/2024 at 17:50, 7 months 25 days ago

Xebra Brands Ltd Partners with Restorative Botanicals for CBD Product Launch

Sustainable Practices CBD Products Xebra Brands Restorative Botanicals Mexican Market
PRESS RELEASE

published on 03/26/2024 at 17:45, 7 months 25 days ago

Xebra Brands Ltd Executes Manufacturing Agreement with Restorative Botanicals
Xebra Brands Ltd. partners with Restorative Botanicals for manufacturing agreement, launching premium CBD tinctures in Mexico, enhancing product portfolio and commercial pathways

Mexico Manufacturing Agreement Xebra Brands Ltd. Restorative Botanicals CBD Tinctures
BRIEF

published on 03/21/2024 at 21:55, 7 months 30 days ago

Xebra Brands Concludes Debt Settlement With Shares Issuance and Grants New Options

Stock Options Debt Settlement Cannabis Industry Securities Regulation Xebra Brands
PRESS RELEASE

published on 03/21/2024 at 21:50, 7 months 30 days ago

Xebra Brands Announces Closing of Shares for Debt Transaction and Grants Options
Xebra Brands Ltd. finalizes Debt Settlement by issuing 4,848,909 shares at $0.055 per share to officers, directors, and consultants. Company grants 3,200,000 stock options. Shares subject to hold period. Exemptions applied for related party transactions

Stock Options Debt Settlement Shares For Debt Transaction Related Party Transaction Xebra Brands Ltd.

Accesswire

Published on 11/21/2024 at 12:00, 44 minutes ago

Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 44 minutes ago

Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 14 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 2 hours 41 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours 44 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 12:35, 9 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 29 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 38 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 44 minutes ago

Holding(s) in Company
Published on 11/21/2024 at 11:30, 1 hour 14 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived

Les Echos

Published on 11/21/2024 at 06:58, 5 hours 46 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 17 hours 24 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 18 hours 59 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 18 hours 59 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 4 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE